Tekla Capital Management LLC Galera Therapeutics, Inc. Call Options Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GRTX
# of Institutions
38Shares Held
10.7MCall Options Held
10.3KPut Options Held
0-
Gsa Capital Partners LLP London, X03.63MShares$435,9150.04% of portfolio
-
Blackstone Inc New York, NY1.68MShares$201,4780.0% of portfolio
-
Abrdn PLC898KShares$107,8040.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3613KShares$73,5860.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA448KShares$53,7990.0% of portfolio
About Galera Therapeutics, Inc.
- Ticker GRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,821,600
- Market Cap $3.22M
- Description
- Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...